<DOC>
	<DOCNO>NCT01919125</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics ( PK ) safety tolerability single-dose administration IDX719 participant normal hepatic function participant vary degree hepatic impairment .</brief_summary>
	<brief_title>Pharmacokinetics IDX719 Participants With Normal Impaired Hepatic Function ( MK-1894-008 )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>Read sign write informed consent form ( ICF ) nature study fully explain . All subject childbearing potential must agree use double method birth control ( one must barrier ) Screening least 90 day last dose study drug . Male subject agree donate sperm Day 1 90 day last dose study drug . Pregnant breastfeeding . Other clinically significant medical condition laboratory abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Chronic hepatitis C</keyword>
	<keyword>Hepatitis C virus</keyword>
	<keyword>HCV</keyword>
</DOC>